The 3′ end of the tale—neglected isoforms in cancer
FEBS Letters · 2025
DOI: 10.1002/1873-3468.70122 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift FEBS Letters, 2025. Verfasst von Didem Naz Dioken und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Middle East Technical University, Ankara, Türkiye. Hauptthemen laut MEDLINE: Neoplasms, 3' Untranslated Regions, RNA, Messenger, RNA Isoforms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 165 Literaturangaben. Gefördert von: Orta Doğu Teknik Üniversitesi, Türkiye Bilimsel ve Teknolojik Araştırma Kurumu.
Abstract (Originalsprache)
The evolutionary expansion of 3′ untranslated regions (3′UTRs), along with the incorporation of transposable elements and alternative polyadenylation (APA) sites, has introduced additional layers of gene expression control in eukaryotes. Consequently, 3′UTRs regulate the stability, translation, and localization of mRNAs by interacting with RNA‐binding proteins and non‐coding RNAs, thereby contributing to cell‐type‐specific and context‐dependent gene expression. Mounting evidence highlights the importance of non‐coding regions, particularly 3′UTRs, in normal physiology and disease states, including cancer. Genomic alterations and driver mutations in coding regions play a well‐established role in cancer biology. Advances in long‐read sequencing and 3′UTR‐focused genome‐/transcriptome‐wide association studies (GWAS/TWAS) improve our understanding of transcriptome complexity and how mRNA isoforms with different 3′‐ends may impact protein functions. This Review explores the regulatory roles of 3′UTRs, sources of 3′UTR isoform diversity, and implications in cancer, emphasizing the need for further research into their diagnostic and therapeutic potential. Impact statement This review highlights how alternative polyadenylation generates diverse mRNA 3′‐end isoforms in cancer. Isoforms with distinct 3′UTRs are differentially regulated by microRNAs and RNA‐binding proteins, while intronically polyadenylated isoforms can lead to C‐terminally truncated proteins with altered functions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences, Middle East Technical University, Ankara, Türkiye.
- Cancer Systems Biology Laboratory, CanSyL, METU, Ankara, Türkiye.
ORCID-Profile: Ayse Elif Erson-Bensan
Förderung
- Orta Doğu Teknik Üniversitesi
- Türkiye Bilimsel ve Teknolojik Araştırma Kurumu
Zitieren
APA
Dioken, D. N., Ozgul, I., & Erson-Bensan, A. E. (2025). The 3′ end of the tale—neglected isoforms in cancer. FEBS Letters. https://doi.org/10.1002/1873-3468.70122
Vancouver
Dioken DN, Ozgul I, Erson-Bensan AE. The 3′ end of the tale—neglected isoforms in cancer. FEBS Letters. 2025. doi:10.1002/1873-3468.70122
BibTeX
@article{Dioken2025,
author = {Dioken, Didem Naz and Ozgul, Ibrahim and Erson-Bensan, Ayse Elif},
title = {The 3′ end of the tale—neglected isoforms in cancer},
journal = {FEBS Letters},
year = {2025},
doi = {10.1002/1873-3468.70122}
}
EUVIMED